SCHEMBL28030648

SCHEMBL28030648

CCCOc1ccccc1SNC(N)=O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.48
LMNA P02545 3/20 0.48
ALDH1A1 P00352 2/20 0.48
HTT P42858 2/20 0.48
PKM P14618 1/20 0.48
NLRP1 Q9C000 1/20 0.48
HSD17B10 Q99714 2/20 0.47
GAA P10253 2/20 0.45
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
NR1I2 O75469 1/20 0.44
CHRM2 P08172 1/20 0.44
CYP3A4 P08684 1/20 0.44
ADRA2A P08913 1/20 0.44
OPRK1 P41145 1/20 0.44
HTR2B P41595 1/20 0.44
SLC6A3 Q01959 1/20 0.44
HDAC6 Q9UBN7 1/20 0.44
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8842551 0.80 HTT (0.51) MAPTLMNAALDH1A1HTTHSD17B10
SCHEMBL10748359 0.75 MAPT (0.72) MAPTLMNAALDH1A1HTTPKM
SCHEMBL2983050 0.74 ACHE (0.40) MAPTLMNAALDH1A1HSD17B10GAA
SCHEMBL28861802 0.74 CTNNB1 (0.51) LMNAHTTPKMGAAMEN1
SCHEMBL942882 0.73 CYP1A2 (0.46) MAPTLMNAALDH1A1HTTPKM
SCHEMBL7642520 0.73 HSD17B10 (0.46) ALDH1A1HTTHSD17B10GAAMEN1
SCHEMBL28016848 0.73 GAA (0.40) ALDH1A1GAACYP3A4HDAC6CYP2C9
SCHEMBL6768095 0.72 CYP1A2 (0.44) MAPTLMNAALDH1A1HTTGAA
Bicarbonate SCHEMBL28180169 0.72 ACHE (0.38) MAPTLMNAALDH1A1HTTGAA
SCHEMBL9632083 0.71 GPBAR1 (0.48) MAPTLMNAALDH1A1HSD17B10MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105121437-B Coumarin derivative and method for treating cystic fibrosis, chronic obstructive pulmonary disease and misfolded protein matter illness 发现生物医药公司 2018-12-04 CN disclosed
CN-105246887-B Coumarin derivative and the method for treating hyperproliferative disease 发现生物医药公司 2018-05-11 CN disclosed
CN-105246887-A Coumarin derivatives and methods of use in treating hyperproliferative diseases DISCOVERYBIOMED INC 2016-01-13 CN disclosed
CN-105121437-A Coumarin derivatives and methods of use in treating cystic fibrosis, chronic obstructive pulmonary disease, and misfolded protein disorders DISCOVERYBIOMED INC 2015-12-02 CN disclosed